Cytomegalovirus

Clinical Neurovirology

Volumn , Issue , 2003, Pages 177-205

  Pomeroy, Claire ^a,b   Ribes, Julie A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870477928     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (132)

1. Crumpacker, C.S. Cytomegalovirus. In Principles and Practices of Infectious Diseases, 5th ed.; Mandell, G.L., Bennett, J.E., Dolin, R., Eds.; Churchill Livingston: Philadelphia, 2000, 1586–1598.
2. Griffiths, P.D.; Emery, V.C. Cytomegalovirus. In Clinical Virology; Richman, D.D., Whitley, R.J., Hayden, F.G., Eds.; Churchill Livingstone: New York, 1997, 445–470.
3. Drew, W.L.; Lalezari, J.P. Cytomegalovirus: disease syndromes and treatment. Curr. Clin. Top. Infect. Dis. 1999, 19, 16–29.
4. Stagno, S. Cytomegalovirus. In Infectious Diseases of the Fetus and Newborn Infant, 4th ed; Remington, J.S., Klein, J.O., Eds.; WB Saunders: Philadelphia, 1995, 312–353.
5. Lange, M.; Klein, E.B.; Kornfield, H.; Cooper, L.Z.; Grieco, M.H. Cytomegalovirus isolation from healthy homosexual men. JAMA. 1984, 252, 1908–1910.
6. Pomeroy, C.; Englund, J.A. Cytomegalovirus: epidemiology and infection control. Am. J. Infect. Control. 1987, 15, 107–119.
7. Boppana, S.B.; Rivera, L.B.; Fowler, K.B.; Mach, M.; Britt, W.J. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N. Engl. J. Med. 2001, 344, 1366–1371.
8. Pickering, L.K.: Infections in day care. Pediatric. Infect. Dis. J. 1987, 6, 614–617.
9. Jellinger, K.A.; Setinek, U.; Drlicek, M.; Bohm, G.; Steurer, A.; Lintner, F.: Neuropathology and general autopsy findings in AIDS during the last 15 years. Acta. Neuropathol. 2000, 100, 213–220.
10. Wiley, C.A.; Schrier, R.D.; Denaro, F.J.; Nelson, J.A.; Lampert, P.W.; Oldstone, M.B.: Localization of cytomegalovirus proteins and genome during fulminant central nervous system infection in an AIDS patients. J. Neuropathol. Exp. Neurol. 1986, 45, 127–139.
11. Emory, V.C.: Investigation of CMV disease in immunocompromised patients. J. Clin. Pathol. 2001, 54, 84–88.
12. Soderberg-Naucler, C.; Fish, K.N.; Nelson, J.A. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell. 1997, 91, 119–126.
13. Naniche, D.; Oldstone, M.B. Generalized immunosuppression: how viruses undermine the immune response. Cell. Mol. Life Sci. 2000, 57, 1399–1407.
14. Bale, J.F.: Human herpesviruses and neurological disorders of childhood. Semin. Pediatr. Neurol. 1999, 6, 247–287.
15. Bale, J.F.: Human cytomegalovirus infection and disorders of the nervous system. Arch. Neurol. 1984, 41, 310–320.
16. Brown, H.L.; Abernathy, M.P. Cytomegalovirus. Semin. Perinatal. 1998, 22, 260–266.
17. Ahlfors, K.; Ivarsson, S.A.; Harris, S.: Report on a long-term study of maternal and congenital CMV infection in Sweden. Scand. J. Infect. Dis. 1999, 31, 443–457.
18. Jacobson, M.A.: Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 1997, 337, 105–114.
19. Baumal, C.R.; Levin, A.V.; Read, S.E. Cytomegalovirus retinitis in immunosuppressed children. Am. J. Opthalmol. 1999, 127, 550–558.
20. Bowen, E.F. Cytomegalovirus reactivation in patients infected with HIV: the use of polymerase chain reaction in prediction and management. Drugs. 1999, 57, 735–741.
21. Bowen, E.F.; Emery, V.C.; Wilson, P.; Johnson, M.A.; Davey, C.C.; Sabin, C.A.; Farmer, D.; Griffiths, P.D. Cytomegalovirus polymerase chain reaction viraemia in patients receiving ganciclovir maintenance therapy for retinitis. AIDS. 1998, 12, 605–611.
22. Casado, J.L.; Arrizabalaga, J.; Montes, M.; Marti-Belda, P.; Tural, C.; Pinilla, J.; Gutierrez, C.; Portu, J.; Schuurman, R.; Aguirrebengoa, K. Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study Group. AIDS. 1999, 13, 1497–1502.
23. Jabs, D.A.; Forman, M.; Enger, C.; Jackson, J.B.: Comparison of cytomegalovirus loads in plasma and leukocytes of patients with cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group. J. Clin. Microbiol. 1999, 37, 1431–1435.
24. Doan, S.; Cochereau, I.; Guvenisik, N.; Diraison, M.C.; Mousalatti, H.; Thanh, H.X.: Cytomegalovirus retinitis in HIV-infected patients with and without highly active antiretroviral therapy. Am. J. Ophthalmol. 1999, 128, 250–251.
25. Casado, J.L.; Perez-Elias, M.J.; Marti-Belda, P.; Antela, A.; Suarez, M.; Ciancas, E.; Frutus, B.; Perez, M.D.; Guerrero, A. Improved outcome of cytomegalovirus retinitis in AIDS patients after introduction of protease inhibitors. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 1998, 19, 130–134.
26. Reed, J.B.; Schwab, I.R.; Gordon, J.; Morse, L.S. Regression of cytomegalovirus retinitis associated with protease inhibitor treatment in patients with AIDS. Am. J. Ophthalmol. 1997, 124, 199–205.
27. Martin, D.; Dunn, J.P.; Davis, J.L.; Duker, J.S.; Engstrom, R.E., Jr.; Friedberg, G.J.; Jaffe, D.N.; Kuppermann, B.D.; Polis, M.A.; Whitley, R.J.; Wolitz, R.A.; Benson, C.A. Use of ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy: recommendations of an International AIDS Society-USA panel. Am. J. Ophthalmol. 1999, 127, 329–339.
28. Deayton, J.R.; Wilson, P.; Sabin, C.A.; Davey, C.C.; Johnson, M.A.; Emery, V.C.; Griffiths, P.D. Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy. AIDS. 2000, 14, 1163–1170.
29. Whitcup, S.M.; Fortin, E.; Lindblad, A.S.; Griffiths, P.; Metcalf, J.A.; Robinson, M.R.; Masnischewitz, M.R.; Baird, B.; Perry, C.; Kidd, I.M.; Vrabec, T.; Davey, R.T.; Falloon, J.; Walker, R.E.; Kovacs, J.A.; Lane, H.C.; Nussenblatt, R.B.; Smith, J.; Masur, H.; Polis, M.A. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet. 1997, 349, 1443.
30. Jacobson, M.A.; Zegans, M.; Pavan, P.R.; O’Donnell, J.J.; Sattler, F.; Rao, N.; Owens, S.; Pollard, R. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet. 1997, 349, 1443.
31. Jacobson, M.A.; Stanley, H.; Holtzer, C.; Margolis, T.P.; Cunningham, E.T.: Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy. Clin. Infect. Dis. 2000, 30, 231–233.
32. Torriani, F.J.; Freeman, W.R.; Macdonald, J.C.; Karavellas, M.P.; Durand, D.M.; Jeffrey, D.D.; Meylan, P.R.A.; Schrier, R.D. CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy. AIDS. 2000, 14, 173–180.
33. Zegans, M.E.; Walton, R.C.; Holland, G.N.; O’Donnell, J.J.; Jacobson, M.A.; Margolis, T.P.: Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am. J. Ophthalmol. 1998, 125, 292–300.
34. Karavellas, M.P.; Lowder, C.Y.; Macdonald, C.; Torriani, F.J.; Shufelt, C.L.; Azen, S.P.; Freeman, W.R. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome. Arch. Ophthalmol. 1998, 116, 169–175.
35. Eddleston, M.; Peacock, S.; Juniper, M.; Warrel, D.A. Severe cytomegalovirus infection in immunocompetent patients. Clin. Infect. Dis. 1997, 24, 52–56.
36. Phillips, A.C.; Fanning, W.L.; Diter, W.G.; Phillips, C.V. Cytomegalovirus encephalitis in immunologically normal adults. JAMA. 1977, 238, 2299–2300.
37. Prosch, S.; Schielke, E.; Reip, A.; Meisel, H.; Volk, H-D.; Einhaupl, K.M.; Kruger, D.H. Human cytomegalovirus (HCMV) encephalitis in an immunocompetent young person and diagnostic reliability ofHCMV DNA PCR using cerebrospinal fluid of nonimmunosuppressed patients. J. Clin. Microbiol. 1998, 36, 3636-3640.
38. Studahl, M.; Ricksten, A.; Sandberg, T.; Elowson, S.; Herner, S.; Sall, C.; Berstrom, T. Cytomegalovirus infection of the CNS in non-compromised patients. Acta. Neurol. Scand. 1994, 89, 451–457.
39. Arribas, J.R.; Storch, G.A.; Clifford, D.B.; Tselis, A.C. Cytomegalovirus encephalitis. Ann. Intern. Med. 1996, 125, 577–587.
40. Roullet, E.: Opportunistic infections of the central nervous system during HIV-1 infection (emphasis on cytomegalovirus disease). J. Neurol. 1999, 246, 237–243.
41. Milazzo, L.; Di Marco, A.; Gervasoni, C.; Rusconi, S.; Negri, C. Hearing loss as a presentation of CMV encephalitis in an HIV-1-infected patient. Infect. Med. 2000, 17, 495–499.
42. Grassi, M.P.; Clerici, F.; Perin, C.; Monforte, A.D.; Vago, L.; Borella, M.; Boldorini, R.; Mangoni, A. Microglial nodular encephalitis and ventriculoencephalitis due to cytomegalovirus infection in patients with AIDS: two distinct clinical patterns. Clin. Infect. Dis. 1998, 27, 504–508.
43. Kalayjian, R.C.; Cohen, M.L.; Bonomo, R.A.; Flanigan, T.P. Cytomegalovirus ventriculoencephalitis in AIDS: a syndrome with distinct clinical and pathologic features. Medicine. 1993, 72, 67–77.
44. McCutchan, J.A.: Clinical impact of cytomegalovirus infections of the nervous system in patients with AIDS. Clin. Infect. Dis. 1995, 21((suppl 2)), S196–S201.
45. McCutchan, J.A.: Cytomegalovirus infections of the nervous system in patients with AIDS. Clin. Infect. Dis. 1995, 20, 747–754.
46. Morgella, S.; Cho, E-S.; Nielsen, S.; Devinsky, O.; Petito, C.K. Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: an autopsy study of 30 cases and a review of the literature. Hum. Pathol. 1987, 18, 289–297.
47. Miles, C.; Hoffmann, W.; Lai, C-W. Cytomegalovirus-associated transverse myelitis. Neurology. 1993, 43, 2143–2145.
48. Giobbia, M.; Carniato, A.; Scotton, P.G.; Marchiori, G.C.; Vaglia, A. Cytomegalovirus associated transverse myelitis in a non-immunocompromised patient. Infection. 1999, 27, 228–230.
49. Shahid, M.B.; Ata Kan, M. Cytomegalovirus-associated transverse myelitis in a non-immunocompromised patient. J. Neurol. Sci. 1995, 134, 210–211.
50. Cohen, B.A.; McArthur, J.C.; Grohman, S.; Patterson, B.; Glass, J.D. Neurologic prognosis of cytomegalovirus polyradiculomyelopathy in AIDS. AIDS. 1993, 43, 493–499.
51. Said, G.; Lacroix, C.; Chemouilli, P.; Goulon-Goeau, C.; Roullet, E.; Penaud Brouker, T.; Meduri, G.; Vincent, D.; Torchet, M. Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and pathological study. Ann. Neurol. 1991, 29, 139–145.
52. Roullet, E.; Assuerus, V.; Gozlan, J.; Ropert, A.; Said, G.; Baudrimont, M.; Jacomet, C.; Duvivier, C.; Gonzales-Canali, G. Cytomegalovirus multifocal neuropathy in AIDS: analysis of 15 consecutive cases. Neurology. 1994, 44, 2174–2182.
53. So, Y.T.; Olney, R.K. Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: experience in 23 patients. Ann. Neurol. 1994, 35, 53–58.
54. Behar, R.; Wiley, C.; McCutchan, A. Cytomegalovirus polyradiculoneuropathy in acquired immune deficiency syndrome. Neurology. 1987, 37, 557–561.
55. Olney, R.K. Acute lumbosacral polyradiculopathy in AIDS: experience in 23 patients. Ann. Neurol. 1994, 35, 53–58.
56. de Gans, J.; Portegies, P.; Tiessens, G.; Troost, D.; Danner, S.A.; Lange, J.M. Therapy for cytomegalovirus polyradiculomyelitis in patients with AIDS: treatment with ganciclovir. AIDS. 1990, 4, 421–425.
57. Granter, S.R.; Doolittle, M.H.; Renshaw, A.A. Predominance of neutrophils in the cerebrospinal fluid of AIDS patients with cytomegalovirus radiculopathy. Am. J. Clin. Pathol. 1996, 105, 364–366.
58. Miller, R.F.; Fox, J.D.; Thomas, P.; Waite, J.C.; Sharvell, Y.; Gazzard, B.G.; Harrison, M.J.; Brink, N.S. Acute lumbosacral polyradiculopathy due to cytomegalovirus in advanced HIV disease: cerebrospinal fluid findings in 17 patients. J. Neurol. Neurosurg. Psychiatr. 1996, 61, 456–460.
59. Clifford, D.B.; Buller, R.S.; Mohammed, S.; Robison, L.; Storch, G.A. Use of polymerase chain reaction to demonstrate cytomegalovirus DNA in CSF of patients with human immunodeficiency virus infection. Neurology. 1993, 43, 75–79.
60. Mahieux, F.; Gray, F.; Fenelon, G.; Gherardi, R.; Admas, D.; Guillard, A. Acute myeloradiculitis due to cytomegalovirus as the initial manifestation of AIDS. J. Neurol. Neurosurg. Psychiatry. 1989, 52, 270–274.
61. Fuller, G.N.: Cytomegalovirus and the peripheral nervous system in AIDS. J. Acquired. Immune. Defic. Syndr. 1992, 5(suppl 1), S33–S36.
62. Wolf, D.G.; Spector, S.A. Diagnosis of human cytomegalovirus central nervous system disease in AIDS patients by DNA amplification from cerebrospinal fluid. J. Infect. Dis. 1992, 166, 1412–1415.
63. Schmitz, H.; Enders, G. Cytomegalovirus as a frequent cause of Guillain-Barre syndrome. J. Med. Virol. 1977, 1, 21–27.
64. deMaar, E.F.; Kas-Deelen, D.M.; de Jager, A.E.J.; The, H.; Tegzess, A.M.; van Son, W.J. Inflammatory demyelinating polyneuropathy in a kidney transplant patient with cytomegalovirus infection. Nephrol. Dial. Transplant. 1999, 14, 2228–2230.
65. Clifford, D.B.; Arribas, J.R.; Storch, G.A.; Tourtellote, W.; Wippold, F.J. Magnetic resonance brain imaging lacks sensitivity for AIDS associated cytomegalovirus encephalitis. J. Neurovirol. 1996, 2, 397–403.
66. Holland, N.R.; Power, C.; Mathews, V.P.; Glass, J.D.; Forman, M.; McArthur, J.C. Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS). Neurology. 1994, 44, 507–514.
67. Price, T.A.; Digioia, R.A.; Simon, G.L. Ganciclovir treatment of cytomegalovirus ventriculitis in a patient infected with human immunodeficiency virus. Clin. Infect. Dis. 1992, 15, 606–608.
68. Mussini, C.; Mongiardo, N.; Manicardi, G.; Trenti, F.; Alessandri, A.; Paolillo, F.; Catania, A.; Portolani, M.; Pecorari, M.; Borghi, V.; Ficarra, G.; Cossarizza, A.; Rienzo, B.: Relevance of clinical and laboratory findings in the diagnosis of cytomegalovirus encephalitis in patients with AIDS. Eur. Clin. Microbiol. Infect. Dis. 1997, 16, 437–444.
69. Burke, D.G.; Leonard, D.G.B.; Imperiale, T.F.; Valdez, H.; Karaman, B.; Shick, E.; Kalayjian, R.C. The utility of clinical and radiographic features in the diagnosis of cytomegalovirus central nervous system disease in AIDS patients. Mol. Diagn. 1999, 4, 37–43.
70. Moulignier, A.; Mikol, J.; Gonzalez-Canali, G.; Polivka, M.; Pialoux, G.; Welker, Y.; Alain, S.; Thiebaut, J.B.; Dupont, B. AIDS-associated cytomegalovirus infection mimicking central nervous system tumors: a diagnostic challenge. Clin. Infect. Dis. 1996, 22, 626–631.
71. Anders, H.J.; Goebel, F.D. Cytomegalovirus polyradiculopathy in patients with AIDS. Clin. Infect. Dis. 1998, 2, 345–352.
72. Ginocchio, C.C.: Laboratory diagnosis of human cytomegalovirus (HCMV) central nervous system disease in AIDS patients. Int. J. Antimicrob Agents. 2000, 16, 447–453.
73. Gleaves, C.A.; Smith, T.F.; Shuster, A.; Pearson, G.R.: Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low speed centrifugation and monoclonal antibody to early antigen. J. Clin. Microbiol. 1984, 19, 917–919.
74. Rabella, N.; Drew, W.L.: Comparison of conventional and shell vial cultures for detecting cytomegalovirus infection. J. Clin. Microbiol. 1990, 28, 806–807.
75. Weinberg, A.; Spiers, D.; Cai, G.-Y.; Long, C.M.; Sun, R.; Tevere, V. Evaluation of a commercial PCR kit for diagnosis of cytomegalovirus infection of the central nervous system. J. Clin. Microbiol. 1998, 36, 338–384.
76. Vinters, H.V.; Kwok, M.K.; Ho, H.W.; Anders, K.H.; Tomiyasu, U.; Wolfson, W.L.; Robert, F. Cytomegalovirus in the nervous system of patients with the acquired immune deficiency syndrome. Brain. 1989, 112, 245–268.
77. Boeckh, M.; Boivin, G. Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin. Microbiol. Rev. 1998, 11, 533–554.
78. Revello, M.G.; Percivalle, E.; Sarasini, A.; Baldanti, F.; Furione, M.; Gerne, G. Diagnosis of human cytomegalovirus infection of the nervous system by pp65 detection in polymorphonuclear leukocytes of cerebrospinal fluid from AIDS patients. J. Infect. Dis. 1994, 170, 1275–1279.
79. Flood, J.; Drew, W.L.; Miner, R.; Jekic-McMullen, D.; Shen, L.P.; Kolberg, J.; Garvey, J.; Follansbee, S.; Poscher, M. Diagnosis of cytomegalovirus polyradiculopathy and documentation of in vivo anti-CMV activity in cerebrospinal fluid by using branched DNA signal amplification and antigen assays. J. Infect. Dis. 1997, 176, 348–352.
80. Cinque, P.; Vago, L.; Brytting, M.; Castagna, A.; Accordini, A.; Sundqvist, V.-A.; Zanchetta, N.; Monforte, A.D.; Wahren, B.; Lazzarin, A.; Linde, A. Cytomegalovirus infection of the central nervous system in patients with AIDS: diagnosis by DNA amplification from cerebrospinal fluid. J. Infect. Dis. 1992, 166, 1408–1411.
81. Gozlan, J.; Amrani, M.E.; Baudrimont, M.; Costagliola, D.; Salord, J.M.; Duvivar, C.; Picard, O.; Meyohas, M.-C.; Jacomet, C.; Schneider-Fauveau, V.; Petit, J.-C.; Roullet, E. A prospective evaluation of clinical criteria and polymerase chain reaction assay of cerebrospinal fluid for the diagnosis of cytomegalovirus-related neurological diseases during AIDS. AIDS. 1995, 9, 253–260.
82. Gozlan, J.; Salord, J.-M.; Roullet, E.; Baudrimont, M.; Caburet, F.; Picard, O.; Meyohas, M.-C.; Duvivier, C.; Jacomet, C.; Petit, J.-C. Rapid detection of cytomegalovirus DNA in cerebrospinal fluid of AIDS patients with neurologic disorders. J. Infect. Dis. 1992, 166, 1416–1421.
83. Linde, A.; Klapper, P.E.; Monteyne, P.; Echevarri, J.M.; Cinque, P.; Rozenberg, F.; Vestergaard, B.F.; Ciardi, M.; Lebon, P.; Cleator, G.N. and the EU Concerted Action on Virus Meningitis and Encephalitis. Specific diagnostic methods for herpesvirus infections of the central nervous system: a consensus review by the European Union Concerted Action on Virus Meningitis and Encephalitis. Clin. Diagn. Virol. 1997, 8, 83–104.
84. Cohen, B.A. Prognosis and response to therapy of cytomegalovirus encephalitis and meningomyelitis in AIDS. Neurology. 1996, 46, 444–450.
85. Kuhn, J.E.; Wendland, T.; Eggers, H.J.; Lorentzen, E.; Wieland, U.; Eing, B.; Kiessling, M.; Gass, P. Quantitation of human cytomegalovirus genomes in the brain of AIDS patients. J. Med. Virol. 1995, 47, 70–82.
86. Wolf, D.G.; Spector, S.A. Diagnosis of human cytomegalovirus central nervous system disease in AIDS patients by DNA amplification from cerebrospinal fluid. J. infect. Dis. 1992, 166, 1412–1415.
87. Achim, C.L.; Nagra, R.M.; Wang, R.; Nelson, J.A.; Wiley, C.A. Detection of cytomegalovirus in cerebrospinal fluid autopsy specimens from AIDS patients. J. Infect. Dis. 1994, 169, 623–627.
88. Minjolle, S.; Michelet, C.; Jusselin, I.; Joannes, M.; Cartier, F.; Colimon, R. Amplification of the six major human herpesviruses from cerebrospinal fluid by a single PCR. J. Clin. Microbiol. 1999, 37, 950–953.
89. Quereda, C.; Corral, I.; Laguna, F.; Valencia, M.E.; Tenorio, A.; Echeverria, J.E.; Navas, E.; Martin-Davila, P.; Moreno, A.; Moreno, V.; Gonzalez-Lahoz, J.M.; Arribas, J.R.; Guerrero, A. Diagnostic utility of a multiplex herpesvirus PCR assay performed with cerebrospinal fluid from human immunodeficiency virus-infected patients with neurological disorders. J. Clin. Microbiol. 2000, 38, 3061–3067.
90. Yamamoto, T.; Nakamura, Y. A single tube PCR assay for simultaneous amplification of HSV-1/-2, CMV, HHV-6A/-6B, and EBV DNAs in cerebrospinal fluid from patients with virus related neurological diseases. J. Neurovirol. 2000, 6, 410–417.
91. Arribas, J.R.; Clifford, D.B.; Fichtenbaum, C.J.; Commins, D.L.; Powderly, W.G.; Storch, G.A.: Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. J. Infect. Dis. 1995, 172, 527–531.
92. Fillet, A.M.; Katlama, C.; Camilleri, S.; Rogequx, O.; Huraux, J.M. Human CMV infection of the CNS: concordance between PCR detection in CSF and pathologic examination. AIDS. 1993, 7, 1016–1018.
93. Wildemann, B.; Hass, J.; Lynen, N.; Stingele, K.; Storch-Hagenlocher, B. Diagnosis of cytomegalovirus encephalitis in patients with AIDS by quantitation of cytomegalovirus genomes in cells of cerebrospinal fluid. Neurology. 1998, 50, 693–697.
94. Cinque, P.; Baldanti, F.; Vago, L.; Terreni, M.R.; Lillo, F.; Furione, M.; Castagna, A.; Monforte, A.D.; Lazzarin, A.; Linde, A. Ganciclovir therapy for cytomegalovirus infection of the central nervous system in AIDS patients: monitoring by CMV DNA detection in cerebrospinal fluid. J. Infect. Dis. 1995, 171, 1603–1606.
95. Shinkai, M.; Spector, S.A. Quantitation of human cytomegalovirus DNA in cerebrospinal fluid by competitive PCR in AIDS patients with different HCMV central nervous system diseases. Scand. J. Infect. Dis. 1995, 27, 559–561.
96. Wattanamano, P.; Clayton, J.L.; Kopicko, J.J.; Kissinger, P.; Elliot, S.; Jarrott, C.; Rangan, S.; Beilke, M.A. Comparison of three assays for cytomegalovirus detection in AIDS patients at risk for retinitis. J. Clin. Microbiol. 2000, 38, 727–732.
97. Zhang, F.; Tetali, S.; Wang, X.P.; Kaplan, M.H.; Cromme, F.V.; Ginocchio, C.C. Detection of human cytomegalovirus pp67 late gene transcripts in cerebrospinal fluid of human immunodeficiency virus type 1-infected patients by nucleic acid sequence-based amplification. J. Clin. Microbiol. 2000, 38, 1920–1925.
98. Crumpacker, C.S. Ganciclovir. N. Engl. J. Med. 1996, 335, 721–729.
99. Erice, A.: Resistance of human cytomegalovirus to antiviral drugs. Clin. Microbiol. Rev. 1999, 12, 286–297.
100. Martin, D.F.; Parks, D.J.; Mellow, S.D.; Ferris, F.L.; Walton, R.C.; Remaley, N.A.; Chew, E.Y.; Ashton, P.; Davis, M.D.; Nussenblatt, R.B. Treatment of cytomegalovirus retinitis with intraocular sustained–release ganciclovir implant. A randomized controlled clinical trial. Arch. Ophthalmol. 1994, 112, 1531–1539.
101. Musch, D.C.; Martin, D.F.; Gordon, J.F.; Davis, M.D.; Kuppermann, B.D. and the Ganciclovir Implant Study Group. Treatment of cytomegalovirus retinitis with a sustained release ganciclovir implant. N. Engl. J. Med. 1997, 337, 83–90.
102. Martin, D.F.; Kuppermann, B.D.; Wolitz, R.A.; Palestine, A.G.; Li, H.; Robinson, C.A. and the Roche Ganciclovir Study Group. Oral ganciclovir for patients with CMV retinitis treated with a ganciclovir implant. N. Engl. J. Med. 1999, 340, 1063–1070.
103. Drew, W.L.; Ives, D.; Lalezari, J.P.; Crumpacker, C.; Follansbee, S.E.; Spector, S.A.; Benson, C.A.; Friedberg, D.N.; Hubbard, L.; Stempien M.J., et al., Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. N. Engl. J. Med. 1995, 333, 615–620.
104. Brosgart, C.L.; Louis, T.A.; Hillman, D.W.; Craig, C.P.; Alston, B.; Fisher, E.; Abrams, D.I.; Luskin-Hawk, R.L.; Sampson, J.H.; Ward, D.J.; Thompson, M.A.; Torres, R.A. A. randomized placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV–infected individuals. AIDS. 1998, 12, 269–277.
105. Spector, S.A.; McKinley, G.F.; Lalezari, J.P.; Samo, T.; Andruczk, R.; Follansbee, S.; Sparti, P.D.; Havlir, D.V.; Simpson, G.; Buhles, W.; Wong, R.; Stempien, M. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. N. Engl. J. Med. 1996, 334, 1491–1497.
106. Jabs, D. CMV and herpesvirus infections. Presented at the 8th Conference on Retroviruses and Opportunistic Infections: Chicago; Feb 4–8, 2001, Session 66.
107. Jayaweera, D.T.: Minimising the dosage-limiting toxicities of foscarnet induction therapy. Drug. Saf. 1997, 16, 258–266.
108. Plosker, G.L.; Noble, S. Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS. Drugs. 1998, 58, 325–345.
109. Studies of the Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group. Long term follow–up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. AIDS. 2000, 14, 1571–1581.
110. Hoffman, V.F.; Skiest, D.J. Therapeutic developments in cytomegalovirus retinitis. Expert. Opin. Investig. Drugs. 2000, 9, 207–220.
111. Whitley, R.J.; Cloud, G.; Gruber, W.; Storch, G.A.; Demmler, G.J.; Jacobs, R.F.; Dankner, W.; Spector, S.A.; Starr, S.; Pass, R.F.; Stagno, S.; Britt, W.J.; Alford, C.; Soong, S.-J.; Zhou, X.-J.; Sherrill, L.; FitzGerald, J.M.; Sommadossi, J.-P. and the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. J. Infect. Dis. 1997, 175, 1080–1086.
112. Akerele, T.; Lightman, S. Current and novel agents for the treatment of cytomegalovirus retinitis. Drugs. 1999, 2, 289–297.
113. Holbrook, J.T.; Davis, M.D.; Hubbard, L.D.; Martin, B.K.; Holland, G.N.; Jabs, D.A.; Gilpin, A.K.; Meinert, C.; Reshef, D.S. Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Studies of Ocular Complications of AIDS Research Group. Arch. Ophthalmol. 2000, 118, 1196–1204.
114. Ives, D.V. Cytomegalovirus disease in AIDS. AIDS. 1997, 11, 1791–1797.
115. Whitley, R.J.; Jacobson, M.A.; Friedberg, D.N.; Holland, G.N.; Jabs, D.A.; Dieterich, D.T.; Hardy, W.D.; Polis, M.A.; Deutsch, T.A.; Feinberg, J.; Spector, S.A.; Walmsley, S.; Drew, W.L.; Powderly, W.G.; Griffiths, P.D.; Benson, C.A.; Kessler, H.A. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society—USA. Arch. Intern. Med. 1998, 158, 957–969.
116. Phillips, P.: Management of cytomegalovirus retinitis in AIDS. Eur. J. Clin. Microbiol. Infect. Dis. 2000, 19, 571–584.
117. Studies of the Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N. Engl. J. Med. 1992, 326, 213–220.
118. Studies of the Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Ophthalmology. 1994, 101, 1250–1261.
119. Studies of the Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group. Combination foscarnet and ganciclovir therapy vs monotherapy for treatment of relapsed cytomegalovirus retinitis in patients with AIDS: the Cytomegalovirus Retreatment Trial. Arch. Ophthalmol. 1996, 114, 23–33.
120. Whitcup, S.M. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy. JAMA. 2000, 283, 653–657.
121. Johnson, S.C.; Benson, C.A.; Johnson, D.W.; Weinberg, A.: Recurrences of cytomegalovirus retinitis in a HIV-infected patient, despite antiretroviral therapy and apparent immune reconstitution. Clin. Infect. Dis. 2001, 32, 815–819.
122. Komanduri, K.V.; Feinberg, J.; Hutchins, R.K.; Frame, R.D.; Schmidt, D.K.; Viswanathan, M.N.; Kalezari, J.P.; McCune, J.M.: Loss of cytomegalovirus-specific CD4+T cell responses in human immunodeficiency type 1-infected patients with high CD4+ T cell counts and recurrent retinitis. J. Infect. Dis. 2001, 183, 1285–1289.
123. Anduze-Faris, B.M.; Fillet, A.-M.; Gozlan, J.; Lancar, R.; Boukli, N.; Gasnault, J.; Caumes, E.; Livartowsky, J.; Matheron, S.; Leport, C.; Salmon, D.; Costagliola, D.; Katlama, C. Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients. AIDS. 2000, 14, 517–524.
124. deGans, J.; Portegies, P.; Tiessens, G.; Troost, D.; Danner, S.A.; Lange, J.M. Therapy for cytomegalovirus polyradiculomyelitis in patients with AIDS: treatment with ganciclovir. AIDS. 1990, 4, 421–425.
125. Miller, R.G.; Storey, J.R.; Greco, C.M. Ganciclovir in the treatment of progressive AIDS related polyradiculopathy. Neurology. 1990, 40, 569–574.
126. Anders, H.J.; Weiss, N.; Bogner, J.R.; Goebel, F.D.: Ganciclovir and foscarnet efficacy in AIDS-related CMV polyradiculopathy. J. Infect. 1998, 36, 29–33.
127. Decker, D.F.; Tarver, J.H.; Murray, D.F.; Martin, G.J.: Prolonged concurrent use of ganciclovir and foscarnet in the treatment of polyradiculopathy due to cytomegalovirus in a patient with AIDS. Clin. Infect. Dis. 1994, 19, 548–549.
128. Jacobson, M.A.; Mills, J.; Rush, J.; O’Donnell, J.J.; Miller, R.G.; Greco, C.: Failure of antiviral therapy for acquired immunodeficiency syndrome-related cytomegalovirus myelitis. Arch. Neurol. 1988, 45, 1090–1092.
129. Karmochkine, M.; Molina, J.M.; Scieux, C.: Combined therapy with ganciclovir and foscarnet for cytomegalovirus polyradiculopathy in patients with AIDS. Am. J. Med. 1994, 97, 196–197.
130. Tokumoto, J.I.N.; Hollander, H. Cytomegalovirus polyradiculopathy caused by a ganciclovir resistant strain. Clin. Infect. Dis. 1993, 17, 854–856.
131. Kim, Y.S.; Hollander, H. Polyradiculopathy due to cytomegalovirus: report of two cases in which improvement occurred after prolonged therapy and review of the literature. Clin. Infect. Dis. 1993, 17, 32–37.
132. Kader, J.G. Leukocyte-reduced blood products. Curr. Opin. Hematol. 1998, 5, 381–385.